Why Haven't We Cured Cancer Yet? - Gayatri Arun, Ph.D.

TL;DR

Cancer is complex with diverse types requiring specific treatments.

Transcript

hi I'm Gayatri i'm a postdoc and researcher here at the Cold Spring Harbor labs today I'm going to be talking about one of the mind-boggling questions most of us have why haven't we cured cancer yet so I started my research career not just asking this question but also trying to find solution of how we can cure cancer in order to understand cancer ... Read More

Key Insights

• Cancer arises from uncontrolled cell division, depleting nutrients and compromising organ function. It can also spread to distant organs, complicating treatment.
• Each type of cancer, such as blood, skin, or breast cancer, is unique, with various subtypes having different genetic abnormalities, making universal treatment difficult.
• Traditional therapies like chemotherapy and radiotherapy often fail to distinguish between cancerous and normal cells, leading to potential relapse and disease spread.
• Targeted therapy aims to identify and attack molecules specific to cancer cells, sparing normal cells and potentially improving treatment specificity and effectiveness.
• Research focuses on molecules such as DNA, RNA, or proteins unique to cancer cells, which, when targeted, can prevent cancer cell migration and disease spread.
• A successful targeted approach at Cold Spring Harbor Labs identified a molecule that stops cancer cells from migrating, demonstrating the potential of targeted therapies.
• Cancer research is a global effort with scientists developing combinatorial approaches to address the complexity of cancer and its treatment.
• The hope is that ongoing research and targeted therapies will eventually lead to effective cancer cures, changing the narrative from 'why' to 'how' we cured cancer.

Questions & Answers

Q: What makes cancer a complex disease?

Cancer is complex due to its diverse types and subtypes, each with unique genetic abnormalities. This diversity means that a universal treatment is ineffective, as each subtype requires a specific strategy. Additionally, cancer's ability to metastasize and affect various organs further complicates treatment efforts.

Q: Why do traditional cancer treatments often fail?

Traditional treatments like chemotherapy and radiotherapy often fail because they cannot distinguish between cancerous and normal cells. This lack of specificity leads to damage to healthy cells and can result in the relapse of the disease, as some cancer cells may remain untreated and continue to spread.

Q: How do targeted therapies improve cancer treatment?

Targeted therapies improve cancer treatment by focusing on molecules specific to cancer cells, such as DNA, RNA, or proteins that are absent in normal cells. This specificity allows for more effective treatment, reducing harm to healthy cells and potentially preventing the spread of cancer by targeting its unique properties.

Q: What is an example of successful targeted therapy research?

At Cold Spring Harbor Labs, researchers identified a molecule that prevents cancer cell migration, a major factor in disease spread. By targeting this molecule, they demonstrated that cancer cells could be prevented from migrating and invading distant organs, showcasing the potential effectiveness of targeted therapies in cancer treatment.

Q: What role does cell migration play in cancer progression?

Cell migration is crucial in cancer progression as it allows cancer cells to spread from their original location to distant organs, a process known as metastasis. This ability to invade other parts of the body complicates treatment and contributes to the severity and lethality of cancer, making it a critical focus for research.

Q: How does cancer affect the body's nutrient supply?

Cancer affects the body's nutrient supply by consuming large amounts of nutrients needed for its rapid and uncontrolled cell division. This depletion of resources can compromise the function of healthy organs, as they are deprived of the nutrients required for normal operation, further exacerbating the disease's impact.

Q: Why is it difficult to develop a universal cancer treatment?

Developing a universal cancer treatment is difficult due to the vast diversity among cancer types and subtypes, each with distinct genetic profiles. This heterogeneity means that a treatment effective for one type may not work for another, necessitating personalized approaches tailored to the specific characteristics of each cancer.

Q: What future advancements are hoped for in cancer research?

Future advancements in cancer research aim to overcome current treatment challenges by developing more effective, targeted therapies that can specifically attack cancer cells without harming healthy ones. The goal is to find cures that address the complexity and diversity of cancer, ultimately shifting the focus from managing to curing the disease.

Summary & Key Takeaways

• Cancer is a complex disease characterized by uncontrolled cell division and the ability to spread, making it challenging to treat. Each cancer type and subtype has unique genetic abnormalities, necessitating specific treatments rather than a one-size-fits-all approach.

• Traditional treatments like chemotherapy and radiotherapy struggle to differentiate between cancerous and normal cells, often leading to relapse. Targeted therapies aim to address this by identifying and attacking molecules specific to cancer cells, sparing normal cells.

• Research at Cold Spring Harbor Labs focuses on identifying molecules that prevent cancer cell migration, a key factor in disease spread. These efforts, combined with global research initiatives, aim to overcome current treatment challenges and move towards effective cancer cures.